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 11 
Abstract 12 
Background: 13 
Adults with primary brain tumors and their caregivers have significant information needs. This 14 
review assessed the effect of interventions to improve information provision for adult primary brain 15 
tumor patients and/or their caregivers.  16 
Methods: 17 
We included randomized or nonrandomized trials testing educational interventions that had outcomes 18 
of information provision, knowledge, understanding, recall, or satisfaction with the intervention, for 19 
adults diagnosed with primary brain tumors and/or their family or caregivers. PubMed, MEDLINE, 20 
EMBASE and Cochrane Reviews databases were searched for studies published between 1980 and 21 
June 2014.  22 
Results: 23 
Two randomized controlled, one non-randomized controlled, and 10 single group pre-post trials 24 
enrolled more than 411 participants. Five group, four practice/process change and four individual 25 
interventions assessed satisfaction (12 studies), knowledge (four studies) or information provision (2 26 
studies). Nine studies reported high rates of satisfaction. Three studies showed statistically significant 27 
improvements over time in knowledge and two showed greater information was provided to 28 
intervention than control group participants, although statistical testing was not performed.  29 
Discussion: 30 
The trials assessed intermediate outcomes such as satisfaction, and only 4/13 reported on knowledge 31 
improvements. Few trials had a randomized controlled design and risk of bias was either evident or 32 
could not be assessed in most domains. 33 
Abstract: 199 words; Manuscript: 1 figure, 3 tables & 1 box, 3962 words34 
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1. Introduction 35 
The provision of appropriate and timely information, tailored to the medical condition, needs and 36 
preferences, is essential to allow patients and their families to cope with the diagnosis, access 37 
supportive resources, and reduce uncertainty and distress (1, 2). Information provision essential for 38 
participation in decision-making and to enable patients to give informed consent for treatment (3-5). 39 
It also may improve compliance with treatment (6). Both during and after active treatment, 40 
information can aid patients and their families to monitor symptoms and undertake self-care. 41 
Information can also assist family members to develop skills to undertake caring tasks (7-9).  42 
A range of strategies have been developed to facilitate information provision in the cancer setting 43 
more widely. Traditional approaches include written information, videos, CD or, more recently, 44 
websites and apps (10, 11). Strategies may also aim to improve communication between patients and 45 
healthcare professionals by means such as treatment summary letters, provision of audio-tapes of 46 
consultations to patients and communication skills training for doctors. These have been developed 47 
and evaluated widely for patients with cancer overall. Promising findings have specifically been 48 
shown with the use of such strategies for those with high needs, including patients requiring 49 
treatment for lung cancer or palliative care, with promising findings (12, 13).  50 
Specifically for patients with brain tumors, studies suggest that they are not satisfied with the 51 
information that they have been provided. Patients want to receive more information, and wish the 52 
information to be more detailed (14-22). Further information is particularly required in two areas:1) 53 
fatigue, insomnia and psychological disturbance (17, 23); and 2) changes in physical function and 54 
body image (24). Caregivers require information on how to provide care (25), and how to manage 55 
physical, cognitive and personality changes in the patient and cope with changes in family roles (26). 56 
The reasons why these needs are not well met are not clear; however certain factors are apparent. In 57 
terms of patient characteristics, distress resulting from the diagnosis may impair some patients’ 58 
abilities to process information, particularly as the brain is commonly understood to define the ‘self’ 59 
(27). Cognitive and physical changes resulting from a brain tumor or its treatment may also impair 60 
information seeking or comprehension for some patients (28). Cognitive impairment is the most 61 
common deficiency in primary brain tumor patients, particularly affecting executive function, 62 
visuoconstructive abilities, attention and verbal memory (29). Memory loss, information processing 63 
and attention are commonly affected by radiotherapy and chemotherapy (30). Deficits may also arise 64 
due to the tumor itself, raised intracranial pressure or as the result of surgery (31). Cognitive 65 
impairment has been shown to affect patients’ awareness of their prognosis and ability to process 66 
information (32). Considering factors relating to healthcare professionals, the information provided 67 
may be insufficient due to clinicians’ views of what patients need. For example, some healthcare 68 
professionals may hold back ‘unnecessary’ information in an attempt to ‘protect’ patients from 69 
distress, particularly with regard to issues such as preparing wills, advanced health directives or the 70 
immediacy of palliative care required (33). Materials used to convey information also have 71 
limitations, as they often require higher levels of literacy than is common in the population (34).  72 
Patient, healthcare professional and interactive issues are also likely to impact how well 73 
interventions aiming to improve information provision will reach patients with brain tumors and 74 
improve their satisfaction with care. Although some (but by no means all) informational interventions 75 
have been well studied in general cancer populations, the cognitive impairments experienced by brain 76 
tumor patients and the resulting concerns of this group are unique, and it cannot be assumed that 77 
interventions will be equally effective when applied to these patients and their caregivers. This 78 
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review thus aimed to examine whether patient-, caregiver- or healthcare professional-directed 79 
interventions improve information provision, satisfaction with the intervention, or other commonly 80 
assessed outcomes (35) such as knowledge, understanding or recall for adults diagnosed with primary 81 
brain tumors and/or their family or caregivers.   82 
2. Methods 83 
2.1. Criteria for considering studies for this review  84 
Randomized and non-randomized trials including single arm studies were eligible for inclusion. To 85 
be included, studies needed to test one or more interventions which tested an educational component 86 
(i.e. involving knowledge transfer, using any format or materials) and which reported one or more of 87 
the outcomes: information provision, knowledge, understanding, recall or satisfaction with the 88 
intervention. There were no language restrictions. Case reports, personal narratives, editorials, 89 
commentaries and reviews were excluded.  90 
As this review was concerned with outcomes for adults diagnosed with primary brain tumors 91 
and/or their informal caregivers, studies with both adults and children needed to report outcomes for 92 
adults (18+ years) and children (<18 years) separately, or at least 75% of the sample needed to be 93 
aged 18+ years. Similarly, at least 75% of patients needed to be diagnosed with primary (malignant 94 
or benign) brain tumors, or outcomes needed to be reported for primary brain tumor patients 95 
separately. Studies involving caregivers were eligible either in conjunction with or separately to 96 
studies involving patients. Caregiver studies were eligible only for informal or family caregivers (i.e. 97 
not paid caregivers or healthcare professionals), although studies involving interventions targeting 98 
healthcare professionals were eligible where the aim of the intervention was to ultimately improve 99 
information provision to primary brain tumor patients or caregivers.       100 
2.2.  Search methods for identification of studies 101 
Searches of PubMed, MEDLINE, EMBASE, CINAHL (via EBSCOhost) and PsychINFO (via 102 
EBSCOhost) were conducted for the years 1980-2014, to identify reports of relevant studies. Search 103 
terms used medical subject headings (MeSH) and keywords relating to brain tumors, patient 104 
education, doctor-patient communication and information provision (see Box 1 for an illustration). 105 
We also reviewed the reference lists of included studies and relevant reviews for further references to 106 
relevant trials. 107 
Box 1 Search terms used for MEDLINE 108 
Search Query content 
S1 Brain Neoplasms (MeSH) 
S2 neurooncology OR neuro-oncology (title/abstract) 
S3 glioma OR glioblastoma OR astrocytoma OR meningioma OR schwannoma OR 
oligodendroglioma OR medulloblastoma OR ependymoma (title/abstract) 
S4 brain tumor OR brain tumour OR brain cancer OR brain neoplasm (title/abstract) 
S5 1 OR 2 OR 3 OR 4 
S6 Patient Education as Topic (MeSH) 
S7 Professional Patient Relations (MeSH) 
S8 Information Dissemination (MeSH) 
S9 Consumer Health Information (MeSH) 
S10 Pamphlets (MeSH) 
S11 Audiovisual aids (MeSH) 
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S12 information provision (title/abstract) 
S13 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 
S14 5 AND 13 
S15 animals NOT humans (MeSH) 
S16 14 NOT 15 
S17 Limit date 1980-June 30 2014 
 109 
2.3. Data collection and analysis 110 
Articles identified from all sources were downloaded into a reference management software package 111 
and duplicates were removed. One author pre-screened all results (titles and abstracts) for possible 112 
inclusion based on the inclusion criteria. The full text of selected articles was then obtained and 113 
assessed against the inclusion criteria. Data were extracted by one author using a template, collecting 114 
study design, population, intervention characteristics and outcomes. Where data were missing or 115 
unclear, or to obtain additional data, we attempted to contact lead study authors, to obtain the data 116 
needed for analyses. Where necessary, titles, abstracts and full text were translated into English to 117 
allow assessment and data collection. 118 
Both authors independently assessed risk of bias in individual studies in seven domains (random 119 
allocation sequence generation, allocation concealment, blinding of participants and personnel, 120 
blinding of outcome assessment, incomplete outcome data, selective outcome reporting, and other 121 
sources of bias), taken from the Cochrane Handbook of Systematic Reviews (36). Non-randomized 122 
and single arm studies were assessed and reported as being at a high risk of bias on the random 123 
allocation sequence generation and allocation concealment items of the ‘Risk of bias’ tool. Risk of 124 
bias ratings were compared and consensus reached. 125 
We had planned to pool the data across studies statistically using meta-analysis but the 126 
heterogeneity in intervention types, outcomes and study designs meant the data were unsuitable for 127 
this. We have thus conducted a narrative synthesis of results, grouping the data based on the category 128 
that best explores the heterogeneity of studies, in this case nature of the intervention (group level, 129 
practice or process change, or individual level). Within each category we narratively summarised the 130 
results.  131 
3. Results 132 
3.1. Search results  133 
Eight hundred and thirty nine original articles were identified, 48 of which were assessed at the full 134 
text level for eligibility. The screening and selection process is outlined in a PRISMA flow chart, see 135 
Figure 1. 136 
3.2. Included studies  137 
A total of 16 articles reporting on 13 studies involving more than 210 patients, 87 caregivers and 104 138 
healthcare professionals were selected for inclusion (Tables 1 and 2). Studies for which quantitative 139 
data were available are described in Table 1; Table 2 reports on the studies for which no quantitative 140 
results were reported. Two studies were randomized controlled trials (37, 38), one was a non-141 
randomized trial with control group (39), and the remainder were single arm trials (40-48). Studies 142 
were most commonly conducted in the US (6 studies (38, 41-44, 46)) and Australia (3 studies (39, 143 
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47)), with single studies conducted in Canada (40), Austria (45), the Netherlands (37), and the UK 144 
(48). Six studies involved patients only (37-39, 41, 42, 48), two targeted caregivers only (43, 47), two 145 
healthcare professionals only (44, 47), and two both patients and caregivers (45, 46). A single study 146 
reported patient and healthcare professional participants (40), although only the patient participants 147 
were eligible for and included in this review. Four studies did not specify the sample size (43, 48), or 148 
data collection was in progress at the time of reporting (37, 42). Median participant sample sizes 149 
were 32 (range 13-50) for patients, 39 (range 7-41) for caregivers, and 52 (range 43-61) for 150 
healthcare professionals. One study was published only as a protocol (37), and four studies only in 151 
conference abstracts (41-43, 46). An attempt was made to contact corresponding authors of all 152 
included studies in order to verify methods and to obtain missing data, and six authors responded to 153 
requests for additional information. 154 
   Five interventions were delivered at the group level, four intervened to facilitate practice or process 155 
changes, and four were individual level interventions. At the group level, two workshops provided 156 
training in using compensatory strategies to manage challenging behaviors; one half-day duration 157 
workshop delivered by a multi-disciplinary group covering didactic sessions and clinician-facilitated 158 
discussions was for family members (47) and the other six hour workshop, also led by a multi-159 
disciplinary team and involving didactic presentations and small-group exercises, was for healthcare 160 
professionals (47). A further workshop of eight hours’ duration provided training for family members 161 
to develop practical care skills and provide information about brain tumors (43). Schratter-Sehn (45) 162 
and colleagues described a mixed patient/family member information and support group, which took 163 
place monthly with flexible attendance. Rabow and colleagues (44) developed and screened a 48 164 
minute documentary film for neurosurgeons, neuro-oncologists and other clinicians to teach them 165 
about family caregiving for patients with brain tumors.  166 
At the practice or process level, Lima and colleagues (42) described an evaluation currently in 167 
progress of a new survivorship care model involving nurse practitioner survivorship visits in 168 
coordination with neuro-oncologists. This intervention includes scheduled survivorship visits, a 169 
personalized education notebook, calendar, pedometer and “walking challenge”, electronic medical 170 
record-created “After Visit Summary” and written summaries sent to all treatment team members. 171 
Delaney and colleagues (40) described the integration of a pharmacist into the neurooncology team, 172 
with the pharmacist meeting with or telephoning patients three times during their course of 173 
chemotherapy, and returning patient-initiated calls during this time. Pharmacists provided 174 
standardized counseling regarding chemotherapy administration, managing side effects, dosing of 175 
supportive medications and drug interactions, and communication with pharmacists, and answered 176 
other medication-related questions. Green and colleagues described the use of a videoconferencing 177 
system to allow brain tumor patients to undergo follow-up neuro-oncology visits at a medical center 178 
closer to home, rather than having to attend a tertiary hospital further away. Following the taking of 179 
history and physical examination, clinical and laboratory data and neuro-images were shared by 180 
desktop by a neuro-oncologist located at the tertiary center. Finally within this category, Grimes and 181 
colleagues described the evaluation of changes to a number of processes within a hospital 182 
neurosciences service. Changes included documentation for staff relating to the patient admission 183 
process; training programs for staff relating to the communication of “bad news” to patients; 184 
documentary information for patients and families covering types of disease, treatment and support 185 
services; new systems for the management of scans and biopsy results; and a half hour preparation 186 
session for patients held at the beginning of each neuro-oncology clinic, during which patients were 187 
allocated to a single clinician based on their needs (rather than seeing each clinician as done 188 
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previously).          189 
At the individual level, a wide variety of interventions were evaluated. El-Jawahri and colleagues 190 
(38) tested a six-minute video designed to facilitate end-of-life discussions in a randomized 191 
controlled trial. The video depicted life-prolonging care (for example, including cardiopulmonary 192 
resuscitation (CPR), intubation and mechanical ventilation), basic care (including hospitalisation, 193 
intravenous fluids and antibiotics but excluding CPR, etc) and comfort care (usually including 194 
medications to improve symptoms but not hospitalisation). Boele and colleagues (37) described a 195 
self-administered internet-based intervention based on problem-solving therapy for glioma patients 196 
with mild to moderate depressive symptoms. The intervention consisted of five modules with text 197 
and exercises, with feedback provided by a personal coach. Spezeski and colleagues (46) described 198 
the evaluation of a neuro-oncology information hotline which patients and caregivers could call as 199 
desired and which covered topics ranging from brain tumor types and treatments, caregiving issues, 200 
symptom management, and referrals to support-related resources. Langbecker and colleagues (39) 201 
tested a brain tumor-specific question prompt list, which is a structured list of questions for patients 202 
to ask of healthcare professionals if they wish and which may foster the provision of tailored, 203 
personally relevant information.  204 
The most commonly reported outcome was satisfaction with the intervention, assessed in some 205 
form (e.g. found the intervention helpful or acceptable) by 12 of the 13 studies (37-47, 49-52). Four 206 
studies assessed knowledge by questionnaire (38, 43, 47) in terms of knowledge of different levels of 207 
medical care in the advanced stage of cancer (38), knowledge and use of compensatory strategies to 208 
manage behavioral and cognitive changes (47), or caregiver knowledge not further defined (43). Two 209 
studies assessed information provision (39, 48). No studies assessed recall or understanding, and only 210 
two studies assessed more distal outcomes such as quality of life (37, 39). Outcomes were most 211 
commonly assessed immediately after the intervention (37, 38, 44, 47), although the timing of 212 
assessment was not clear in six studies (41-43, 45, 46, 48). 213 
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Table 1 Characteristics of Included Studies Reporting Quantitative Results 214 
Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Randomized controlled trials 
El-Jawahri 
et al. 2010 
(38, 51) 
 
(US) 
50 Consecutive patients 
with malignant 
glioma, recruited via 
hospital oncology 
outpatient clinics  
Video after verbal narrative, 
describing 3 levels of medical care 
in advanced cancer (life-prolonging 
care, basic medical care, comfort 
care). 6 minute video shown on 
portable computer included visual 
images of the goals of care 
described verbally. Comparison: 
verbal narrative only 
Knowledge (goals of care 
options assessed via 
questionnaire, yielding 
score 0-6). Patient 
satisfaction (perceived value 
of video, 3 items on 4-point 
Likert scale) assessed for 
intervention group only, 
immediately after 
intervention 
Significantly higher mean 
increase in knowledge score 
for intervention (mean 1.9, 
95% CI, 1.3 to 2.4) than 
control group (mean 0.9, 95% 
CI, 0.4 to 1.3), p=0.004. Most 
intervention participants were 
“very comfortable” watching 
the video (82.6%), found it 
“very helpful” (78.3%) & 
would “definitely recommend 
it” (82.6%) 
Non-randomized trials with control group 
Langbecker 
et al. 2012 
(39, 49, 50) 
 
(Australia) 
20 Primary brain tumor 
patients diagnosed in 
previous 6 months 
and/or undergoing 
treatment, recruited 
via 4 hospitals  
Brain tumor specific question 
prompt list (booklet with list of 
questions patients may wish to ask) 
designed to facilitate patient-HCP 
communication with questions 
about: diagnosis; prognosis; 
symptoms & changes; treatment; 
support; after treatment finishes; 
the healthcare professional team. 
Control participants given standard 
brochure only 
Quantity & quality of 
information received 
(assessed using EORTC 
QLQ-INFO25 
questionnaire); satisfaction 
(acceptability of the 
intervention or standard 
brochure assessed using 17 
questions, combined into 
summative index), collected 
4-6 weeks after intervention 
Higher median change in 
information received for 
intervention (2.7, range -24.0 
to 18.6, n=9) than control 
group (-2.0, range -36.0 to 
9.3, n=8), indicating greater 
information received. Median 
acceptability score higher for 
intervention (31, range 27-34) 
than control group (28, range 
15-31), indicating greater 
acceptability 
Single arm studies 
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Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Grimes 
2000 (48) 
 
(UK) 
NS Patients with brain 
tumors using a 
neurosciences 
service at a hospital  
1) new package of patient 
admission process documentation 
covering issues to discuss 
with/communicate to patients at 
appropriate points during their stay; 
2) procedures to reduce time 
waiting for biopsy result & for 
nurse to coordinate meeting to 
delivery results to patient; 3) 
communication training 
programmes for staff; 4) 
information to familiarize patients 
with the hospital & covering types 
of diseases, treatments & support 
services 
Patients’ views on clarity of 
explanation, collected via 
survey using visual 
analogue scales following 
patients’ receipt of their 
biopsy results. Collected 
prior to & 6 months after 
implementation of 
intervention 
At baseline, 48% rated clarity 
of explanation; this was 73% 
after intervention (no data 
supplied to interpret result) 
Delaney et 
al. 2009 
(40) 
 
(Canada) 
13 Consecutive newly 
diagnosed HGG 
patients undertaking 
chemoradiotherapy 
at a neuro-oncology 
outpatient clinic  
Pharmacist integration into 
multidisciplinary team. Initially 
took medication history & provided 
counseling re: chemotherapy 
administration; side effect 
management; dosing of supportive 
medications; drug interactions; 
communication with pharmacists; 
other medication-related questions. 
Called patient the next day & 5 
days after treatment initiation to 
address medication-related 
questions & review treatment 
protocols; patient could also initiate 
contact 
Patient satisfaction 
(perceptions of the 
pharmacist and benefit of 
their involvement in their 
healthcare team), collected 
at the end of the 3-month 
study 
11/11 participants reported 
receiving useful information 
from pharmacist; 8/10 felt 
pharmacist’s presence was 
helpful in their initial 
consultation; 7/10 said 
pharmacist’s call on day 5 of 
treatment was useful; 8/10 
said pharmacist answered 
additional drug-related 
questions to their satisfaction; 
9/10 recommend pharmacist 
remains part of team 
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Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Green et al. 
2014 (41) 
 
(US) 
38 Patients with 
primary brain tumors 
living regionally 
from a Neuro-
oncology Center 
Use of a videoconferencing system 
for neuro-oncology follow-up 
visits, involving history-taking, 
physical examination, desktop 
sharing of clinical & laboratory 
data using an electronic medical 
record, sharing of neuro-images 
Patient satisfaction (16 
question online survey), 
timing unclear 
Average level of satisfaction 
reported by patients was 9.8 
(1-10 scale, SD not reported) 
Rabow et 
al. 2010 
(44) 
 
(US) 
61 Neurosurgeons, 
neuro-oncologists & 
other clinicians  
from a neurological 
surgery or integrated 
medicine department 
or attending national 
conferences  
48 minute documentary film 
entitled “The Caregivers” depicting 
stories of 4 family caregivers of 
adults with brain tumors & 
designed to improve neurosurgery 
training around supporting family 
caregivers. Screenings held for staff 
& at conferences 
Satisfaction (perceived 
quality of the film, 
perceived importance; belief 
they learned something 
from the film, believe that 
the film was an effective 
way to teach about family 
caregivers, belief that the 
film should be seen by all 
clinicians caring for patients 
with brain tumors, collected 
on 10 point Likert scale) 
immediately after screening 
Mean scores: 9.27 for quality; 
9.03 for importance; 9.67 for 
learning something new; 8.98 
for the film being an effective 
way to teach; 9.23 for the film 
should be seen by all 
clinicians (SDs not reported) 
Schratter-
Sehn et al. 
2010 (45) 
 
(Austria) 
10
4 
Patients with high 
grade glioma 
(glioblastoma, mixed 
glioma & 
astrocytoma) & their 
relatives recruited 
through neuro-
oncology ward at 
hospital  
Interdisciplinary group intervention 
led by a psychologist & physician, 
offered monthly, for participants to 
receive or exchange information. 
Flexible group therapy with 6-10 
participants covering up to 2 
therapy units (1.5 hours). Aims: to 
be responsive to each participant’s 
needs & develop coping strategies, 
based on principle of ‘care, 
encourage, inform and guide’ 
Satisfaction (how much 
participants liked the 
intervention) assessed via 
questionnaire, timing 
unclear 
92% of participants said the 
intervention provided a 
context in which they could 
openly talk about their 
anxieties, concerns & needs. 
93% indicated their questions 
were answered through the 
intervention. Requirements & 
expectations were met for 
82% of patients & 78% of 
relatives 
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Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Whiting et 
al. 2012 
study 1 (47, 
52) 
 
(Australia) 
7 Family caregivers of 
adult primary brain 
tumor patients who 
had participated in 
previous descriptive 
study  
Half-day didactic workshop 
delivered by multidisciplinary team 
to train family members in 
compensatory strategy use to 
manage challenging behaviors 
(reasons for, types of & strategies 
for managing behavioral & 
cognitive changes). Caregivers & 
patients attended sessions together 
with clinician-facilitated discussion  
Knowledge & use of 
compensatory strategies, 
measured via Strategy Use 
Measure (SUM-Family), a 
9-item Likert-type scale; 
satisfaction (usefulness of 
each workshop section) 
assessed via questionnaire 
immediately after workshop 
Median SUM-Family global 
scores significantly increased 
from before (3.29, IQR=0.80) 
to after (3.86, IQR=0.81) the 
intervention, p<0.05. Average 
rating of the workshop was 
4.73 (4=good; 5=very good) 
Whiting et 
al. 2012 
study 2 (47, 
52) 
 
(Australia) 
43 HCPs recruited via 
professional 
networks  
6 hour workshop delivered by 
multidisciplinary team including 
didactic presentations & small 
group exercises covering the 
journey of a brain tumor patient, 
description of challenging 
behaviors & prevalence following 
brain tumor; principles of behavior 
management; case study & group 
activity 
Knowledge of 
compensatory strategies 
measured via Strategy Use 
Measure (SUM), a 16-item 
Likert-type scale developed 
for study); satisfaction 
(evaluation of all sections of 
workshop) assessed 
immediately after workshop 
Average SUM rating scores 
significantly increased from 
before (3.17) to after (4.1) the 
intervention (SDs not 
provided, paired t-test 
p<0.001). Satisfaction mean 
scores were ≥4 (4=good; 
5=very good) 
HCP: healthcare professional; CNS: central nervous system; NS: not specified; EORTC QLQ-INFO25: European Organisation for Research 215 
& Treatment of Cancer Information module; SD: standard deviation; IQR: interquartile range  216 
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Table 2 Characteristics of Included Studies Not Reporting Quantitative Results 217 
Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Randomized controlled trials 
Boele et al. 
2014 (37) 
 
(The 
Netherlands) 
NS Adult grade II, III or 
IV glioma patients 
with mild-moderate 
depressive 
symptoms & their 
informal caregivers, 
recruited through 
advertising & 
treating HCPs 
Internet-based self-help course 
based on principles of problem 
solving, with information about 
specific diseases & treatment, and 
psychological impact on everyday 
life. 5 modules (text & exercises), 2 
hrs/week over 5 weeks. Feedback 
from personal coach. Wait list 
control & non-CNS malignancy 
control group 
Satisfaction (usability, 
readability, usefulness of the 
course & coach’s feedback 
assessed by questionnaire) 
immediately & 6 months 
after intervention 
Data collection in progress 
Single arm studies 
Lima et al. 
2013 (42) 
 
(US) 
NS Newly diagnosed 
primary brain tumor 
patients at a 
Comprehensive 
Cancer Center  
Survivorship care delivery model 
involving nurse practitioner 
survivorship visits in coordination 
with primary neuro-oncologist. 
Aims: to identify & manage 
symptoms & distress; patient 
education; facilitation of 
communication among care 
providers; navigation of resources. 
Visits scheduled within 3 weeks of 
diagnosis & at specific points in the 
disease trajectory. Included 
personalized education notebook, 
calendar, pedometer & ‘walking 
challenge’, after visit summary & 
written summaries sent to all 
treatment team members 
Satisfaction regarding initial 
survivorship visit & patient 
education notebook 
(collected by survey), 
timing unclear  
Data collection in progress 
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Study 
(country) 
N Setting & 
participants 
Intervention characteristics & 
comparison 
Outcomes of interest & 
measures 
Reported findings 
according to authors 
Patterson & 
Lovely 
2007 (43) 
 
(US) 
NS Family caregivers of 
brain tumor patients, 
implemented at 
medical centers  
8-hour workshop curriculum 
providing information on topics 
such as medical overview of brain 
tumors, symptom management at 
home, understanding cognitive 
changes, how to safely move a 
patient. Offered by oncology nurses 
& aims to develop practical care 
skills 
Caregiver knowledge 
(measured by 
questionnaire), satisfaction 
(overall benefit of the 
workshop as perceived by 
participants), timing unclear 
No results reported 
Spezeski et 
al. 2007 
(46) 
 
(US) 
75 Callers to a neuro-
oncology telephone 
service (35% 
patients, 52% 
family/friend of 
patient)  
Neuro-oncology information 
telephone line providing 
information on topics such as brain 
tumor types & treatments, 
caregiving issues, symptom 
management, & referrals to 
support-related resources 
Satisfaction (measurement 
tool unclear) 
“Callers expressed 
satisfaction with their 
experience and found the 
information to be quite 
helpful” (p. 549). “Virtually 
all callers said they would 
recommend the hotline to 
others needing information 
about brain tumors” (p. 549) 
HCP: healthcare professional; NS: not specified 218 
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3.3. Risk of bias in included studies  219 
Both randomized controlled trials (37, 38) were rated as low risk for random sequence generation and 220 
allocation concealment. As all other studies were non-randomized or single arm studies, risk was 221 
rated as high for these biases. Blinding of outcome assessment was rated only for the three studies 222 
with control groups, and was rated as high for all three (37, 38, 49) as well as all single arm studies 223 
due to the nature of the interventions. Five studies (38-40, 44, 47) were rated as low risk with regard 224 
to incomplete outcome data, with all other studies rated as unclear risk due to absence of a published 225 
protocol. Only two studies (39, 44) were rated as low risk for selective reporting, with corresponding 226 
authors confirming that all outcomes were reported.  227 
Table 3 Risk of bias for included studies 228 
Study Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
outcome 
assessment 
Incomplete 
outcome data 
Selective 
reporting 
Boele et al. 2014 (37) Low Low  High  Unclear a Unclear a 
El-Jawahri et al. 2010 (38, 51) Low  Low  High  Low  Unclear  
Langbecker et al. 2012 (39, 49, 50) High  High  High  Low  Low  
Grimes 2000 (48) High  High  High  Unclear  Unclear  
Delaney et al. 2009 (40) High  High  High  Low  Unclear  
Green et al. 2014 (41) High  High  High  Unclear  Unclear  
Lima et al. 2013 (42) High  High  High  Unclear a Unclear a 
Patterson & Lovely 2007 (43) High  High  High  Unclear  Unclear  
Rabow et al. 2010 (44) High  High  High  Low  Low  
Schratter-Sehn et al. 2010 (45) High  High  High  Unclear  Unclear  
Spezeski et al. 2007 (46) High  High  High  Unclear  Unclear  
Whiting et al. 2012 study 1 (47, 52) High  High  High  Unclear  Unclear  
Whiting et al. 2012 study 2 (47, 52) High  High  High  Low  Unclear  
a Unclear risk as data collection in progress 229 
3.4. Effects of interventions  230 
The effects of interventions are reported only for the studies described in Table 1, for which 231 
quantitative results are available. Where appropriate, we have highlighted where studies assessed 232 
outcomes but did not report the results of these outcomes. 233 
3.4.1. Outcome: Information provision 234 
One non-randomized study and one single arm study assessed information provision (39, 48). Grimes 235 
(48) compared the views of inpatients on the clarity of information provided to them before and after 236 
intervention implementation. Patient-reported clarity of explanation increased from 48% to 73% after 237 
the intervention (no information was provided to explain how to interpret these percentages). 238 
Langbecker and colleagues (39) assessed the quality and quantity of information received by 239 
participants using the European Organisation for Research and Treatment of Cancer (EORTC) 240 
information module (QLQ-INFO25). In a non-randomized trial, the median change in information 241 
received between baseline and follow-up was higher for intervention group participants (a brain 242 
tumor specific question prompt list) compared to brochure only controls. However, statistical testing 243 
of the significance of these group differences was not reported, and the sample size was small, with 244 
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follow-up data collected for 17 of 20 participants only due to attrition. Overall, both studies showed 245 
greater information was provided to participants who received the interventions compared to those 246 
who did not, although the high risk of bias for both studies for randomization, allocation concealment 247 
and blinding of outcome assessment limits the confidence that can be had in these findings.  248 
 249 
3.4.2. Outcome: Knowledge 250 
One randomized controlled trial (38) tested a video and three single arm pre-/post-test studies (43, 251 
47) tested the effect of workshop-delivered interventions on participants’ knowledge; however no 252 
results were reported for one study which evaluated the effect of a workshop for family members 253 
(43). Among the three studies for which results were available, the randomized controlled trial 254 
showed a statistically significantly greater mean increase in patients’ knowledge of the different 255 
levels of medical care in the advanced stages of cancer for patients who received the video 256 
intervention compared to those who received the control condition (38). Compared to pre-workshop 257 
levels, Whiting and colleagues’ (47) interventions led to statistically significantly increases in 258 
participant knowledge (for family members and for healthcare professionals) following the 259 
workshops.  260 
Although these results are promising, study-specific instruments were used to assess knowledge 261 
for all three of these studies (38, 43, 47). Whiting et al. (47) reported that the instrument (the Strategy 262 
Use Measure) used to assess knowledge for healthcare professionals (and a modified version of this 263 
was also used to assess knowledge for family members) showed strong internal consistency and did 264 
not demonstrate ceiling or floor effects (47). Whilst this psychometric information demonstrates 265 
reliability, the validity of the instrument and its sensitivity to change is unclear.  266 
The contextual significance of these results is also unclear. Statistical significance may be shown 267 
with a large enough sample, even if the clinical or contextual significance of the findings is 268 
unremarkable. However, the sample sizes of three studies were small, including 50 patients (38), 269 
seven family members (47), and 43 healthcare professionals (47). The presence of statistically 270 
significant results with such small samples provides support for the significance of the results, but 271 
further research to validate the instruments and establish the significance of different levels of change 272 
is needed. 273 
Risk of bias was not significantly different across the three studies for which data were available, 274 
so sub-analysis of the impact of risk of bias was not possible. 275 
 276 
3.4.3. Outcome: Satisfaction 277 
Twelve studies (37-47) considered satisfaction with the intervention as an outcome, and nine studies 278 
reported (38-41, 44-47) data relating to this outcome, primarily described as the intervention’s 279 
acceptability, perceived usefulness, value or quality. Among the nine studies for which results were 280 
available, only one study reported comparative data for intervention and control groups; Langbecker 281 
et al. (39) reported that a greater proportion of participants who received a question prompt list 282 
compared to those who received a control brochure highly agreed that the brochure was helpful, 283 
assisted them to ask questions, and other satisfaction items. All other studies, reported satisfaction in 284 
intervention group participants only. They found high rates of satisfaction, evidenced by mean 285 
satisfaction scores of at least 8 out of 10 (or equivalent), or at least 80% of participants selecting the 286 
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highest rating on a Likert-type scale. This was true regardless of the nature of the intervention, 287 
whether it was delivered in a group or individual setting, or constituted a practice or process change, 288 
and regardless of the risk of bias of the studies involved.  289 
4. Discussion 290 
Our findings suggest that if an intervention is provided to patients with brain tumors, their caregivers 291 
or the healthcare professionals who treat these patients, satisfaction ratings improve. These findings 292 
are based largely on non-randomized pre-post single arm intervention studies, mostly with relatively 293 
small sample sizes. Although similar to reports from previous reviews in the wider cancer population, 294 
the analyses focusing on those affected by brain tumors reported here provide additional insight. 295 
First, the review provides evidence for the feasibility of conducting studies with this patient and 296 
caregiver population. This is important as some may doubt that the highly distressed and often 297 
cognitively impaired population may be willing to be included in such investigations. Based on this 298 
review’s findings, those who agree to participate can be reassured that they will benefit at least 299 
subjectively. The reviewed studies also provide suggestions for optimizing data collection in the 300 
brain tumor patient population to reduce study burden, such as collecting data immediately after the 301 
intervention (38) or collecting data by interview rather than self-administered forms (39). Both of 302 
these strategies are recommended for palliative care research and may have value in this population 303 
(53).   304 
   However, the review also highlights a lack of stringent outcome measurements which can be 305 
compared across studies or can be objectivised. This could include standardised tests of knowledge 306 
or improvements in treatment compliance, which often are target aims, but were seldomly formally 307 
assessed. Notable exceptions are the study by El Jawahri et al. (38), who used a standardised 308 
knowledge score as outcome measure, and Langbecker et al. (39), who used an EORTC module to 309 
assess improvements in information. The most appropriate outcomes to measure in future studies 310 
must also be considered. Satisfaction with the intervention was the most commonly assessed 311 
outcome, but this concept lacks theoretical underpinning and may not be a good indicator of 312 
intervention quality (54). The use of global satisfaction ratings is particularly susceptible to the ‘halo 313 
effect’ whereby raters overestimate performance, with global impressions influencing responses to 314 
specific items. In interventions involving health professionals, patients may also report on the 315 
clinicians’ interpersonal skills rather than the clinicians’ technical competence or the intervention’s 316 
usefulness (55, 56). It is hoped that the emergence of standardised tools such as the EORTC QLQ-317 
INFO25 will encourage the assessment of information provision and related constructs, thus 318 
providing greater understanding of whether interventions achieve real change, and allowing 319 
comparison across studies of intervention effects. If satisfaction ratings are to be used, it is 320 
recommended that surveys emphasise that the ratings will be used to improve the intervention (rather 321 
than merely to evaluate it) and include more items assessing specific aspects of the intervention, 322 
rather than using a global rating. Both of these suggestions have been shown to reduce the impact of 323 
the halo effect (56). 324 
The number of studies conducted with this population seemed to increase over time, with several 325 
conducted during the most recent decade. This is promising and may reflect a renewed interest in 326 
improving the treatment outcomes for patients with brain tumors, and also the encouragement 327 
provided through successfully conducted previous studies. Most studies, however, employed research 328 
designs that resulted in either high risk of bias or inability to assess risk of bias, lacking a published 329 
study protocol and a control group in most instances. Although the nature of the interventions mean 330 
that it would not be possible to blind participants to study outcomes, blinding of assessors would be 331 
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feasible. Greater specification of analysis methods (for example, if intention-to-treat analysis was 332 
carried out) is also needed. Finally, none of the included studies investigated whether intervention 333 
efficacy was affected by patients’ cognitive status, despite cognitive impairment being a common 334 
issue in this population (29, 31, 32). This should be considered in future studies.  335 
4.1. Strengths and limitations of this review 336 
To the best of our knowledge, this is the first systematic review of interventions to improve 337 
information provision for adult primary brain tumor patients and their caregivers. Strengths of this 338 
systematic review include the extensive search of the literature in multiple databases, the inclusion of 339 
publications written in languages other than English, and the assessment of risk of bias of included 340 
studies. However, due to the limited number of studies, heterogeneity in interventions and methods, 341 
and inadequate reporting of data for some studies, we were unable to statistically pool the study 342 
results to determine the relative benefit of different interventions. Further work is necessary to 343 
determine the most effective intervention components and most appropriate timing for intervention 344 
delivery, as well as the effect of interventions on more distal outcomes such as quality of life, 345 
treatment adherence or survival.  346 
4.2. Conclusion  347 
This systematic review showed that interventions with an educational component improve 348 
information provision and knowledge for adults with brain tumors, their families and caregivers. 349 
Furthermore, satisfaction with these interventions was high. Although these results are promising, 350 
future efficacy and effectiveness trials with rigorous study designs are needed, particularly to 351 
determine the most useful intervention components and to understand if certain subgroups of the 352 
population are differentially affected. 353 
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